Literature DB >> 22262833

Neurodegeneration induced by clustering of sialylated glycosylphosphatidylinositols of prion proteins.

Clive Bate1, Alun Williams.   

Abstract

The transmissible spongiform encephalopathies, more commonly known as the prion diseases, are associated with the production and aggregation of disease-related isoforms of the prion protein (PrP(Sc)). The mechanisms by which PrP(Sc) accumulation causes neurodegeneration in these diseases are poorly understood. In cultured neurons, the addition of PrP(Sc) alters cell membranes, increasing cholesterol, activating cytoplasmic phospholipase A(2) (cPLA(2)), and triggering synapse damage. These effects of PrP(Sc) are dependent upon its glycosylphosphatidylinositol (GPI) anchor, suggesting that it is the increased density of GPIs that occurs following the aggregation of PrP(Sc) molecules that triggers neurodegeneration. This hypothesis was supported by observations that cross-linkage of the normal cellular prion protein (PrP(C)) also increased membrane cholesterol, activated cPLA(2), and triggered synapse damage. These effects were not seen after cross-linkage of Thy-1, another GPI-anchored protein, and were dependent on the GPI anchor attached to PrP(C) containing two acyl chains and sialic acid. We propose that the aggregation of PrP(Sc), or the cross-linkage of PrP(C), causes the clustering of sialic acid-containing GPI anchors at high densities, resulting in altered membrane composition, the pathological activation of cPLA(2), and synapse damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262833      PMCID: PMC3318732          DOI: 10.1074/jbc.M111.275743

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

2.  Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform.

Authors:  N Naslavsky; R Stein; A Yanai; G Friedlander; A Taraboulos
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

3.  Scrapie prions aggregate to form amyloid-like birefringent rods.

Authors:  S B Prusiner; M P McKinley; K A Bowman; D C Bolton; P E Bendheim; D F Groth; G G Glenner
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

4.  COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform.

Authors:  K Kaneko; M Vey; M Scott; S Pilkuhn; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Lipid rafts: heterogeneity on the high seas.

Authors:  Linda J Pike
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

6.  Cellular prion protein transduces neuroprotective signals.

Authors:  Luciana B Chiarini; Adriana R O Freitas; Silvio M Zanata; Ricardo R Brentani; Vilma R Martins; Rafael Linden
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

Review 7.  A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains.

Authors:  Richard G W Anderson; Ken Jacobson
Journal:  Science       Date:  2002-06-07       Impact factor: 47.728

8.  Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.

Authors:  Yaron Haviv; Dana Avrahami; Haim Ovadia; Tamir Ben-Hur; Ruth Gabizon; Ronit Sharon
Journal:  Arch Neurol       Date:  2008-06

9.  Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells.

Authors:  B Caughey; K Neary; R Buller; D Ernst; L L Perry; B Chesebro; R E Race
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study 1.

Authors:  Kenichi G N Suzuki; Takahiro K Fujiwara; Fumiyuki Sanematsu; Ryota Iino; Michael Edidin; Akihiro Kusumi
Journal:  J Cell Biol       Date:  2007-05-21       Impact factor: 10.539

View more
  14 in total

1.  Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.

Authors:  Clive Bate; William Nolan; Alun Williams
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

2.  Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses.

Authors:  Clive Bate; William Nolan; Harriet McHale-Owen; Alun Williams
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

3.  PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.

Authors:  Karen E Marshall; Andrew Hughson; Sarah Vascellari; Suzette A Priola; Akikazu Sakudo; Takashi Onodera; Gerald S Baron
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

4.  Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.

Authors:  Clive Bate; Alun Williams
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

5.  Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner.

Authors:  Elizaveta Katorcha; Saurabh Srivastava; Nina Klimova; Ilia V Baskakov
Journal:  J Biol Chem       Date:  2016-06-17       Impact factor: 5.157

6.  Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.

Authors:  Clive Bate; William Nolan; Alun Williams
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

7.  Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.

Authors:  Ewan West; Craig Osborne; William Nolan; Clive Bate
Journal:  Biology (Basel)       Date:  2015-06-02

8.  Amyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neurons.

Authors:  Keifer P Walsh; Laurie S Minamide; Sarah J Kane; Alisa E Shaw; David R Brown; Bruce Pulford; Mark D Zabel; J David Lambeth; Thomas B Kuhn; James R Bamburg
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

9.  Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.

Authors:  Victoria Last; Alun Williams; Dirk Werling
Journal:  BMC Neurosci       Date:  2012-08-28       Impact factor: 3.288

10.  Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.

Authors:  Elizaveta Katorcha; Natallia Makarava; Regina Savtchenko; Alessandra D'Azzo; Ilia V Baskakov
Journal:  PLoS Pathog       Date:  2014-09-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.